ID   MP2K7_RAT               Reviewed;         419 AA.
AC   Q4KSH7;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   24-JUL-2024, entry version 133.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 7;
DE            Short=MAP kinase kinase 7;
DE            Short=MAPKK 7;
DE            EC=2.7.12.2 {ECO:0000269|PubMed:10051439};
DE   AltName: Full=JNK-activating kinase 2;
DE   AltName: Full=MAPK/ERK kinase 7;
DE            Short=MEK 7;
DE   AltName: Full=c-Jun N-terminal kinase kinase 2;
DE            Short=JNK kinase 2;
DE            Short=JNKK 2;
GN   Name=Map2k7 {ECO:0000312|EMBL:AAX61178.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:AAX61178.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:AAX61178.1};
RA   Itoh T., Horiuchi M., Itoh A.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000305}
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10051439; DOI=10.1042/bj3380681;
RA   Butterfield L., Zentrich E., Beekman A., Heasley L.E.;
RT   "Stress- and cell type-dependent regulation of transfected c-Jun N-terminal
RT   kinase and mitogen-activated protein kinase kinase isoforms.";
RL   Biochem. J. 338:681-686(1999).
RN   [3]
RP   PHOSPHORYLATION, AND INTERACTION WITH MAPK8/JNK1; MAPK9/JNK2; MAPK10/JNK3;
RP   MAP3K11/MLK3 AND MAP3K5/ASK1.
RX   PubMed=14575811; DOI=10.1016/j.lfs.2003.06.025;
RA   Zhang Q., Tian H., Fu X., Zhang G.;
RT   "Delayed activation and regulation of MKK7 in hippocampal CA1 region
RT   following global cerebral ischemia in rats.";
RL   Life Sci. 74:37-45(2003).
RN   [4]
RP   REVIEW ON ACTIVITY REGULATION.
RX   PubMed=17496909; DOI=10.1038/sj.onc.1210392;
RA   Raman M., Chen W., Cobb M.H.;
RT   "Differential regulation and properties of MAPKs.";
RL   Oncogene 26:3100-3112(2007).
RN   [5]
RP   REVIEW ON FUNCTION.
RX   PubMed=20801953; DOI=10.1093/jb/mvq098;
RA   Asaoka Y., Nishina H.;
RT   "Diverse physiological functions of MKK4 and MKK7 during early
RT   embryogenesis.";
RL   J. Biochem. 148:393-401(2010).
RN   [6]
RP   REVIEW ON REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=21333379; DOI=10.1016/j.ejcb.2010.11.008;
RA   Haeusgen W., Herdegen T., Waetzig V.;
RT   "The bottleneck of JNK signaling: molecular and functional characteristics
RT   of MKK4 and MKK7.";
RL   Eur. J. Cell Biol. 90:536-544(2011).
CC   -!- FUNCTION: Dual specificity protein kinase which acts as an essential
CC       component of the MAP kinase signal transduction pathway. Essential
CC       component of the stress-activated protein kinase/c-Jun N-terminal
CC       kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the
CC       only known kinase to directly activate the stress-activated protein
CC       kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3.
CC       MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation,
CC       but they differ in their preference for the phosphorylation site in the
CC       Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of
CC       the Tyr residue and MAP2K7/MKK7 for the Thr residue. The
CC       monophosphorylation of JNKs on the Thr residue is sufficient to
CC       increase JNK activity indicating that MAP2K7/MKK7 is important to
CC       trigger JNK activity, while the additional phosphorylation of the Tyr
CC       residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific
CC       role in JNK signal transduction pathway activated by pro-inflammatory
CC       cytokines. The MKK/JNK signaling pathway is also involved in
CC       mitochondrial death signaling pathway, including the release cytochrome
CC       c, leading to apoptosis. Part of a non-canonical MAPK signaling
CC       pathway, composed of the upstream MAP3K12 kinase and downstream MAP
CC       kinases MAPK1/ERK2 and MAPK3/ERK1, that enhances the AP-1-mediated
CC       transcription of APP in response to APOE (By similarity).
CC       {ECO:0000250|UniProtKB:Q8CE90, ECO:0000269|PubMed:10051439}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.2;
CC         Evidence={ECO:0000269|PubMed:10051439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.2; Evidence={ECO:0000269|PubMed:10051439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.2;
CC         Evidence={ECO:0000269|PubMed:10051439};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10051439};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation by specific MAP
CC       kinase kinase kinases such as MAP3K1/MEKK1, MAP3K3/MEKK3, MAP3K11/MLK3
CC       and MAP3K12/DLK.
CC   -!- SUBUNIT: Interacts with VRK2 (By similarity). Interacts (via its D
CC       domain) with its substrates MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3.
CC       Interacts (via its DVD domain) with MAP3Ks activators like MAP3K5/ASK1
CC       and MAP3K1/MEKK1. Interacts with MAPK8IP1/JIP1, MAPK8IP2/JIP2 and
CC       MAPK8IP3/JIP3 scaffold proteins. Interacts with RASSF7, the interaction
CC       promotes phosphorylation. Found in a complex with SH3RF1, RAC1,
CC       MAP3K11/MLK3, MAPK8IP1/JIP1 and MAPK8/JNK1. Found in a complex with
CC       SH3RF1, RAC2, MAP3K7/TAK1, MAPK8IP1/JIP1, MAPK8/JNK1 and MAPK9/JNK2 (By
CC       similarity). {ECO:0000250|UniProtKB:O14733,
CC       ECO:0000250|UniProtKB:Q8CE90}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8CE90}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q8CE90}.
CC   -!- DOMAIN: The DVD domain (residues 377-400) contains a conserved docking
CC       site and is found in the mammalian MAP kinase kinases (MAP2Ks). The DVD
CC       sites bind to their specific upstream MAP kinase kinase kinases
CC       (MAP3Ks) and are essential for activation.
CC   -!- DOMAIN: The D domain (residues 37-57) contains a conserved docking site
CC       and is required for the binding to MAPK substrates.
CC   -!- PTM: Activated by phosphorylation on Ser-271 and Thr-275 by MAP kinase
CC       kinase kinases (MAP3Ks). {ECO:0000269|PubMed:14575811}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY879265; AAX61178.1; -; mRNA.
DR   RefSeq; NP_001020596.1; NM_001025425.1.
DR   AlphaFoldDB; Q4KSH7; -.
DR   SMR; Q4KSH7; -.
DR   STRING; 10116.ENSRNOP00000072160; -.
DR   PhosphoSitePlus; Q4KSH7; -.
DR   PaxDb; 10116-ENSRNOP00000058535; -.
DR   PeptideAtlas; Q4KSH7; -.
DR   Ensembl; ENSRNOT00000104881.1; ENSRNOP00000086269.1; ENSRNOG00000001047.7.
DR   Ensembl; ENSRNOT00055006583; ENSRNOP00055005034; ENSRNOG00055004114.
DR   Ensembl; ENSRNOT00060004015; ENSRNOP00060002839; ENSRNOG00060002502.
DR   Ensembl; ENSRNOT00065008700; ENSRNOP00065006161; ENSRNOG00065005808.
DR   GeneID; 363855; -.
DR   KEGG; rno:363855; -.
DR   UCSC; RGD:1560043; rat.
DR   AGR; RGD:1560043; -.
DR   CTD; 5609; -.
DR   RGD; 1560043; Map2k7.
DR   eggNOG; KOG0983; Eukaryota.
DR   GeneTree; ENSGT00940000158914; -.
DR   HOGENOM; CLU_000288_63_23_1; -.
DR   InParanoid; Q4KSH7; -.
DR   OrthoDB; 2900742at2759; -.
DR   Reactome; R-RNO-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   PRO; PR:Q4KSH7; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001047; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   ExpressionAtlas; Q4KSH7; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0008545; F:JUN kinase kinase activity; IDA:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004707; F:MAP kinase activity; ISO:RGD.
DR   GO; GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:RGD.
DR   GO; GO:0140677; F:molecular function activator activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISO:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0071470; P:cellular response to osmotic stress; IDA:RGD.
DR   GO; GO:0072709; P:cellular response to sorbitol; IEP:RGD.
DR   GO; GO:0007254; P:JNK cascade; IDA:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:RGD.
DR   GO; GO:1904355; P:positive regulation of telomere capping; ISO:RGD.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; ISO:RGD.
DR   GO; GO:2000671; P:regulation of motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0009408; P:response to heat; ISO:RGD.
DR   GO; GO:0006970; P:response to osmotic stress; IDA:UniProtKB.
DR   GO; GO:0034612; P:response to tumor necrosis factor; ISO:RGD.
DR   GO; GO:0009411; P:response to UV; ISO:RGD.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB.
DR   CDD; cd06618; PKc_MKK7; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR052468; Dual_spec_MAPK_kinase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR47238; MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5; 1.
DR   PANTHER; PTHR47238:SF2; PROTEIN KINASE DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; ATP-binding; Coiled coil; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Stress response;
KW   Transferase; Tyrosine-protein kinase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O14733"
FT   CHAIN           2..419
FT                   /note="Dual specificity mitogen-activated protein kinase
FT                   kinase 7"
FT                   /id="PRO_0000271407"
FT   DOMAIN          120..380
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          18..77
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          37..57
FT                   /note="D Domain"
FT                   /evidence="ECO:0000250"
FT   REGION          377..400
FT                   /note="DVD domain"
FT                   /evidence="ECO:0000250"
FT   COILED          2..30
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        18..33
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        243
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q13131,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         126..134
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q13131,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         149
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q13131,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            44..45
FT                   /note="Cleavage; by anthrax lethal factor"
FT                   /evidence="ECO:0000250"
FT   SITE            76..77
FT                   /note="Cleavage; by anthrax lethal factor"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O14733"
FT   MOD_RES         271
FT                   /note="Phosphoserine; by MAP3K"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         275
FT                   /note="Phosphothreonine; by MAP3K"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14733"
SQ   SEQUENCE   419 AA;  47536 MW;  60405BF7111E294B CRC64;
     MAASSLEQKL SRLEAKLKQE NREARRRIDL NLDISPQRPR PTLQLPLAND GGSRSPSSES
     SPQHPTPPSR PRHMLGLPST LFTPRSMESI EIDQKLQEIM KQTGYLTIGG QRYQAEINDL
     ENLGEMGSGT CGQVWKMRFR KTGHIIAVKQ MRRSGNKEEN KRILMDLDVV LKSHDCPYIV
     QCFGTFITNT DVFIAMELMG TCAEKLKKRM QGPIPERILG KMTVAIVKAL YYLKEKHGVI
     HRDVKPSNIL LDERGQIKLC DFGISGRLVD SKAKTRSAGC AAYMAPERID PPDPTKPDYD
     IRADVWSLGI SLVELATGQF PYKNCKTDFE VLTKVLQEEP PLLPGHMGFS GDFQSFVKDC
     LTKDHRKRPK YNKLLEHSFI KHYETLEVDV ASWFKDVMAK TESPRTSGVL SQHHLPFFR
//
